CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation ther...
Phase 2
Towson, Maryland, United States and 6 other locations
and in combination with abiraterone in participants with metastatic prostate cancer. The study includes dose-escalation and cohort ...
Phase 1, Phase 2
Fairfax, Virginia, United States and 16 other locations
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Alexandria, Virginia, United States and 38 other locations
This Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.Patients in this stu ...
Phase 2
Fairfax, Virginia, United States and 13 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Baltimore, Maryland, United States and 35 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Towson, Maryland, United States and 51 other locations
Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...
Phase 2
Baltimore, Maryland, United States
The study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalati...
Phase 1
Fairfax, Virginia, United States and 11 other locations
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Bethesda, Maryland, United States and 22 other locations
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...
Phase 1
Bethesda, Maryland, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal